Nov 2 (Reuters) - Trillium Therapeutics Inc TR.TO -
* Says advances TTI-621 into phase 1b cohort expansion enrollment Source text for Eikon: ID:nCCN6rkJYp Further company coverage: TR.TO
Nov 2 (Reuters) - Trillium Therapeutics Inc TR.TO -
* Says advances TTI-621 into phase 1b cohort expansion enrollment Source text for Eikon: ID:nCCN6rkJYp Further company coverage: TR.TO